OGI
OGI
NASDAQ · Pharmaceuticals

Organigram Global Inc

$1.05
-0.02 (-1.87%)
As of Sep 20, 10:35 PM ET ·
Financial Highlights (FY 2026)
Revenue
402.36M
Net Income
-38,432,386
Gross Margin
6.6%
Profit Margin
-9.6%
Rev Growth
+21.1%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 6.6% 6.6% 34.9% 34.9%
Operating Margin -8.4% -7.6% 19.9% 18.1%
Profit Margin -9.6% -9.1% 18.8% 16.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 402.36M 332.15M 81.33M 78.64M
Gross Profit 26.72M 22.05M 28.34M 27.41M
Operating Income -33,959,245 -25,229,751 16.21M 14.22M
Net Income -38,432,386 -28,553,035 15.27M 12.59M
Gross Margin 6.6% 6.6% 34.9% 34.9%
Operating Margin -8.4% -7.6% 19.9% 18.1%
Profit Margin -9.6% -9.1% 18.8% 16.0%
Rev Growth +21.1% +21.1% -3.5% +20.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.06M 19.06M 25.95M 29.36M
Total Equity 85.99M 85.99M 132.90M 143.87M
D/E Ratio 0.22 0.22 0.20 0.20
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -22,020,825 -17,269,096 21.57M 20.37M
Free Cash Flow 16.42M 10.74M